206 related articles for article (PubMed ID: 29634661)
1. Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti.
Batavia AS; Severe P; Lee MH; Apollon A; Zhu YS; Dupnik KM; McNairy ML; Pape JW; Fitzgerald DW; Peck RN
J Hypertens; 2018 Jul; 36(7):1533-1539. PubMed ID: 29634661
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.
Rodríguez-Arbolí E; Mwamelo K; Kalinjuma AV; Furrer H; Hatz C; Tanner M; Battegay M; Letang E;
PLoS One; 2017; 12(3):e0172089. PubMed ID: 28273105
[TBL] [Abstract][Full Text] [Related]
3. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
Ghazi L; Baker JV; Sharma S; Jain MK; Palfreeman A; Necsoi C; Murray DD; Neaton JD; Drawz PE
Am J Hypertens; 2020 Jan; 33(1):43-52. PubMed ID: 31800000
[TBL] [Abstract][Full Text] [Related]
4. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
[TBL] [Abstract][Full Text] [Related]
5. CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
Collins SE; Jean Juste MA; Koenig SP; Secours R; Ocheretina O; Bernard D; Riviere C; Calnan M; Dunning A; Hurtado Rúa SM; Johnson WD; Pape JW; Fitzgerald DW; Severe P
Int J Tuberc Lung Dis; 2015 Jan; 19(1):50-7. PubMed ID: 25519790
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
Brennan AT; Jamieson L; Crowther NJ; Fox MP; George JA; Berry KM; Stokes A; Maskew M; Sanne I; Long L; Cassim N; Rosen S
PLoS One; 2018; 13(10):e0204020. PubMed ID: 30281618
[TBL] [Abstract][Full Text] [Related]
7. Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.
De Socio GV; Ricci E; Maggi P; Parruti G; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Bonfanti P; Pucci G; Schillaci G;
J Hypertens; 2017 Feb; 35(2):409-416. PubMed ID: 28005710
[TBL] [Abstract][Full Text] [Related]
8. Impact of a youth-friendly HIV clinic: 10 years of adolescent outcomes in Port-au-Prince, Haiti.
Reif LK; Bertrand R; Benedict C; Lamb MR; Rouzier V; Verdier R; Johnson WD; Pape JW; Fitzgerald DW; Kuhn L; McNairy ML
J Int AIDS Soc; 2016; 19(1):20859. PubMed ID: 27389256
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hypertension and cardiovascular risk factors among long-term AIDS survivors: A report from the field.
Pierre S; Seo G; Rivera VR; Walsh KF; Victor JJ; Charles B; Julmiste G; Dumont E; Apollon A; Cadet M; Saint-Vil A; Marcelin A; Severe P; Lee MH; Kingery J; Koenig S; Fitzgerald D; Pape J; McNairy ML
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1558-1566. PubMed ID: 31448551
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
[TBL] [Abstract][Full Text] [Related]
12. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
Gesesew HA; Ward P; Woldemichael K; Mwanri L
PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
[TBL] [Abstract][Full Text] [Related]
13. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
14. Retention in Care among Patients with Early HIV Disease in Haiti.
Hennessey KA; Leger TD; Rivera VR; Marcelin A; McNairy ML; Guiteau C; Devieux JG; Marcelin Y; Charles B; Cremieux PY; Koenig SP; Pape JW
J Int Assoc Provid AIDS Care; 2017; 16(6):523-526. PubMed ID: 29187075
[TBL] [Abstract][Full Text] [Related]
15. Integrating hypertension services at an HIV clinic in Port-au-Prince, Haiti: A report from the field.
Walsh KF; Lee MH; Martelly S; Pierre MM; Joseph J; Gustin M; Peck RN; Fitzgerald DW; Pape JW; McNairy M
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1485-1492. PubMed ID: 30259642
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
[TBL] [Abstract][Full Text] [Related]
17. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
Tesfamariam K; Baraki N; Kedir H
BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
Palella FJ; Deloria-Knoll M; Chmiel JS; Moorman AC; Wood KC; Greenberg AE; Holmberg SD;
Ann Intern Med; 2003 Apr; 138(8):620-6. PubMed ID: 12693883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
